Karyopharm Therapeutics Inc. Tax Withholding Paid on Stock Awards
Karyopharm Therapeutics Inc. (KPTI) reported Tax Withholding Paid on Stock Awards of $39.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2019-02-28
- Karyopharm Therapeutics Inc. payment, tax withholding, share-based payment arrangement for fiscal 2016 was $39.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|
| 2016-12-31 | $39.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |